v3.25.2
Equity Compensation
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Equity Compensation

16. Equity Compensation

 

Under the Company’s 2015, 2021 and 2022 Equity Incentive Plans, the number of shares of common stock reserved for issuance under the option plan shall not exceed 10% of the issued and outstanding shares of common stock of the Company, have a maximum term of 10 years, and vest at the discretion of the Board of Directors.

 

All equity-settled, share-based payments are ultimately recognized as an expense in the statement of operations with a corresponding credit to “Additional Paid in Capital.” If vesting periods or other non-market vesting conditions apply, the expense is allocated over the vesting period, based on the best available estimate of the number of share options expected to vest. Estimates are subsequently revised if there is any indication that the number of share options expected to vest differs from previous estimates. Any cumulative adjustment prior to vesting is recognized in the current period. No adjustment is made to any expense recognized in prior periods if share options ultimately exercised are different than that estimated on vesting.

 

Performance Share Units

 

On May 1, 2023, the Company and Steven Rossi reached an agreement to modify 160,000 restricted stock units and 40,000 performance stock units (“PSUs”) issued on November 11, 2022, and December 29, 2021, respectively, and replace them with 200,000 stock options, as described below.

 

On November 11, 2022, 40,000 and 30,000 PSUs granted on December 29, 2021, as described below, were modified to include new terms pertaining to the PSU vesting schedule. The PSUs vest in 5% increments according to the modified schedule that correlates with the Company’s stock price. The first 5% of the PSUs vest upon the Company’s stock price closing at $22.50, 50% will have vested at a closing price of $53.10, and 100% will have vested at a closing price of $137.60 as measured using the volume weighted average of the Company’s common stock for ten (10) consecutive trading days, with over $100,000 of trading volume on each of those days. The fair value of the PSUs was estimated to be $1,254,460. As of June 30, 2025, 7,500 PSUs of the remaining 30,000 PSUs had vested.

 

On December 29, 2021, the Company granted 40,000 and 30,000 PSUs to the Company’s Chief Executive Officer and a director, respectively. The PSUs were to vest in 5% increments according to a schedule that correlates with the Company’s stock price. The first 5% of the PSUs was to have vested upon the Company’s stock price closing at $30.00, 50% was to have vested at a closing price of $165.00, and 100% was to have vested at a closing price of $315.00. The fair value of the PSUs was estimated to be $1,344,570.

 

Stock Options

 

The Company uses the Black-Scholes option pricing model to determine fair value of stock options on the grant date.

 

During the six months ended June 30, 2025, the Company issued 10,000 stock options to a director with an exercise price of $5.95 and an expiration date of March 7, 2035.

 

During the six months ended June 30, 2025, the Company issued 102,600 stock options to various employees and directors with an exercise price of $3.09 and an expiration date of April 4, 2035.

 

 During the six months ended June 30, 2025, the Company issued 30,000 stock options to Steven Rossi with an exercise price of $3.09 and an expiration date of April 4, 2035.

 

On July 23, 2024, the Company engaged in stock option repricing for certain employees, executive officers, and members of the board of directors of the Company. 538,896 stock options’ exercise prices were repriced to $7.042, and all other criteria were unchanged. As a result of the modification in exercise prices, the Company recognized additional expense of $93,140 on the date of modification.

 

During the year ended December 31, 2024, the Company issued 84,860 stock options to employees and directors with exercise prices ranging from $5.20 to $14.10 and expiration dates ranging from February 1, 2029 to November 19, 2034. Of these stock options, 2,040 were subsequently cancelled.

 

 

   June 30, 2025   December 31, 2024 
  

Number of

stock options

  

Weighted

average price

  

Number of

stock options

  

Weighted

average price

 
Balance, beginning of period   579,936   $7.14    506,386   $19.62 
Granted   142,600   $3.29    84,860   $7.70 
Forfeited   (960)  $7.04    (11,310)  $(29.30)
Balance, end of period   721,576   $6.36    579,936   $7.14 

 

    

Range of

Exercise prices

    Outstanding    

Weighted average
life (years)

    

Weighted average

exercise price

    

Exercisable on
June 30, 2025

 
Stock options  $3.09 - 55.00    721,576    7.86   $6.36    192,505 

 

As of June 30, 2025 and December 31, 2024, Terravis Energy Inc., a wholly owned subsidiary of the Company, has the following options outstanding:

 

   June 30, 2025   December 31, 2024 
   Number of
stock options
   Weighted
average price
   Number of
stock options
   Weighted
average price
 
Balance, beginning of period   1,350,000   $0.01    1,350,000   $0.01 
Granted   -   $-    -   $- 
Balance, end of period   1,350,000   $0.01    1,350,000   $0.01 

 

   Range of
Exercise prices
   Outstanding   Weighted average
life (years)
   Weighted average
exercise price
   Exercisable on
June 30, 2024
 
Stock options  $0.01    1,350,000    6.78   $0.01    1,350,000